No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
PharmAust Receives Nearly AU$890,000 Tax Rebate
PharmAust Files Orphan Medicinal Product Designation for Sclerosis Treatment Following Regulatory Guidance
PharmAust Ltd: Appendix 4E and 2024 Annual Report
PharmAust Raises AU$7.8 Million via Share Placement
PharmAust (ASX:PAA) Shareholders Have Earned a 21% CAGR Over the Last Five Years
PharmAust Secures SME Status With European Medicines Agency